Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3402868 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL20241280 | 0.94 | — | — | |
| SCHEMBL601699 | 0.90 | — | — | |
| SCHEMBL15351328 | 0.83 | — | — | |
| SCHEMBL7716964 | 0.77 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL31470338 | 0.75 | — | — | |
| SCHEMBL15677564 | 0.73 | — | — | |
| SCHEMBL19075259 | 0.73 | — | — | |
| SCHEMBL18629462 | 0.73 | — | — | |
| SCHEMBL16576452 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111491930-B | Substituted Indole Compounds Useful as TLR Inhibitors | 百时美施贵宝公司 | 2023-09-26 | — | — | CN | claimed |
| EP-2470527-A1 | ETHER BENZOTRIAZOLE DERIVATIVES | Merck Sharp & Dohme Corp. (US) | 2012-07-04 | — | — | EP | claimed |
| EP-4536356-A1 | PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | Xenon Pharmaceuticals Inc. (CA) | 2025-04-16 | — | — | EP | disclosed |
| CN-119490450-A | Oxime-containing compound and application thereof | 希格生科（深圳）有限公司 | 2025-02-21 | — | — | CN | disclosed |
| US-11976170-B2 | Polybenzoxazole precursor and application thereof | MICROCOSM TECHNOLOGY CO., LTD. (TW) | 2024-05-07 | — | — | US | disclosed |
| CN-115403584-B | 2-thio-2, 3-dihydropyrimidine-4-one derivatives, pharmaceutical compositions, preparation methods and applications thereof | 长春金赛药业有限责任公司 | 2024-04-02 | — | — | CN | disclosed |
| US-20240002395-A1 | COMPOUNDS AND THEIR USE FOR TREATING NEUROPATHIC PAIN | THE JOHNS HOPKINS UNIVERSITY | 2024-01-04 | — | — | US | disclosed |
| WO-2023239729-A1 | PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | XENON PHARMACEUTICALS INC. (CA) | 2023-12-14 | — | — | WO | disclosed |
| CN-111491930-B | Substituted Indole Compounds Useful as TLR Inhibitors | 百时美施贵宝公司 | 2023-09-26 | — | — | CN | disclosed |
| EP-3743430-B1 | AMINOPYRROLOTRIAZINES AS KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2023-08-02 | — | — | EP | disclosed |
| US-20230041833-A1 | Polybenzoxazole Precursor and Application Thereof | MICROCOSM TECHNOLOGY CO., LTD. (TW) | 2023-02-09 | — | — | US | disclosed |
| WO-1998006706-A1 | SUBSTITUTED P-TRIFLUOROMETHYLPHENYLURACILS | BAYER AKTIENGESELLSCHAFT (DE) | 1998-02-19 | — | — | WO | disclosed |
| EP-0498817-B1 | PROCESS FOR PRODUCING FLUORINATED ORGANIC COMPOUNDS | DU PONT (US) | 1994-06-08 | — | — | EP | disclosed |
| US-5171893-A | Process for producing fluorinated organic compounds | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-12-15 | — | — | US | disclosed |
| EP-0498817-A1 | PROCESS FOR PRODUCING FLUORINATED ORGANIC COMPOUNDS. | DU PONT (US) | 1992-08-19 | — | — | EP | disclosed |
| US-5093512-A | PROCESS FOR PRODUCING FLUORINATED ORGANIC COMPOUNDS | E. I. DU PONT DE NEMOURS & CO. (US) | 1992-03-03 | — | — | US | disclosed |
| WO-1991005750-A2 | PROCESS FOR PRODUCING FLUORINATED ORGANIC COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-05-02 | — | — | WO | disclosed |
| EP-0206950-B1 | PROCESS FOR THE PREPARATION OF PERFLUOROALKYL ALCOHOLS | RHONE-POULENC CHIMIE (FR) | 1990-08-22 | — | — | EP | disclosed |
| US-4701569-A | PERFLUOROALKYLATION OF CARBONYL COMPOUNDS IN PRESENCE OF ZINC IN ABSENCE OF ULTRASONIC WAVES | RHONE-POULENC SPECIALTIES CHIMIQUES (FR) | 1987-10-20 | — | — | US | disclosed |
| EP-0206950-A1 | Process for the preparation of perfluoroalkyl alcohols | RHONE-POULENC CHIMIE (FR) | 1986-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002395-A1 | COMPOUNDS AND THEIR USE FOR TREATING NEUROPATHIC PAIN | MRGPRX1, MRGPRX4, MRGPRX2 | ALDH1A1 4126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.